Delivery Order SPE2DB22D1106-SPE2DB24FEZY5

Award Date 7/1/24
Potential Completion Date 7/2/24
Potential Value $7.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA) over a two-year period through June 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company that holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to provide a wide range of...
This federal contract award is for the delivery of 4,566,250,569 units of Epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA). The contract, valued at $7,709.62, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract does not have a set-aside...
This federal contract award is for the delivery of Epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The award, valued at $2,242.95, was made to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract has a firm fixed price and is a delivery order with a completion date of May 16, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company that provides a wide range of medical products and supplies to the U.S. government, particularly the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems. The contract, valued at $7,851.30, is a delivery order under Amerisourcebergen's Indefinite Delivery...
The federal contract award is for the supply of Epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor, through its Corporate Office Division. The contract is a delivery order with a firm fixed price of $2,543.60 and a completion date of May 30, 2024. It is not designated as a set-aside contract. Amerisourcebergen holds a larger...
This federal contract award is for the delivery of Epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA). The contract, valued at $1,347.39, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc. (doing business as Amerisourcebergen), valued at up to $999,999,999.00. The IDC serves as a primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of Epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA). The $1,794.36 contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products...
This federal contract award is for the supply of epinephrine 0.3 mg auto-injectors to the U.S. government. The contract, valued at $4,485.90, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 2025. This IDC serves as the primary...
This federal contract award is for the supply of epinephrine 0.15 mg auto-injectors to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, in the amount of $2,386.10. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is August 23, 2024. The contract is not designated as a set-aside. Amerisourcebergen has been awarded numerous federal contracts by the DLA and other...
The federal contract award is for the delivery of Epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA). The fixed-price, firm-fixed delivery order, valued at $1,861.44, was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of August 26, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FEZY5
    Delivery Order

This federal contract award is for the delivery of Epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract, valued at $7,760.52, was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the federal government. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a wide range of medical products to DLA facilities supporting the Department of Defense worldwide. This specific contract award is not designated as a set-aside. Amerisourcebergen has also been awarded a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

Generated 9/30/24, 4:58 PM